Apricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) developed as a cytidine analogue for the treatment of HIV-1 infection by inhibiting viral DNA synthesis. Structurally related to other… Read more
Apricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) developed as a cytidine analogue for the treatment of HIV-1 infection by inhibiting viral DNA synthesis. Structurally related to other established antivirals like lamivudine and emtricitabine, this agent requires precise analytical monitoring to ensure therapeutic efficacy and safety. The products in this category, including Apricitabine reference standards, related impurities, metabolites, and stable isotope labelled compounds, are critical tools for laboratory professionals conducting rigorous pharmaceutical analysis. These high-quality materials support comprehensive impurity profiling, method validation, and routine quality control protocols. By providing accurately characterized reference materials, these compounds enable researchers and analytical chemists to maintain strict adherence to regulatory standards, facilitate accurate identification of degradants, and ensure reliable quantification throughout the drug development and manufacturing lifecycle of this specific antiretroviral compound.